Pfizer-BioNTech Vaccine Effective Long-Term in Teens; US Vaccine Data in 2076?
November 22, 2021Novartis May Have a Suitor for Sandoz; Merck Closes Acceleron Deal
November 22, 2021The regulator will decide whether to approve Bluebird's treatment by next May, but its evaluation begins more than a year later than the biotech first hoped.
